PROGRAM - 5th International Keloid Symposium - Shanghai, China
Time
Speaker
Title
DAY 1
Friday June 6, 2025
Opening of the 5th International Keloid Symposium
Co-Chair: Michael H Tirgan, MD
Panel Discussion and Q/A
10:00-10:30
Coffee Break
Co-Chair: Frank Nissen, MD, PhD
Panel Discussion and Q/A
12:30-13:30
Lunch Break
Co-Chair: Bingrong Zhou MD, PhD
15:15 – 15:30
Coffee Break
15:30 – 17:30
Co-Chair: Lamont Jones, MD, MBA
Time
Speaker
Title
DAY 2
Saturday June 7, 2025
Co-Chair: Nanze Yu, MD, PhD
Yixin Zhang, MD
Molecular and Immune-Mechanism of Keloid Development.
Mark Fear, PhD
Understanding the Mechanisms of Keloid Recurrence and Exploring Novel Therapeutic Options.
Zhilian Qin, MD
Inhibition ENO1 Expression Targets the Glycolytic and Lactylation to Regulate Keloid Fibroblast Function.
Chenyu Huang, MD
Asporin Inhibits Collagen Matrix-Mediated Intercellular Mechano-Communications Between Fibroblasts during Keloid Progression.
Nanze Yu, MD, PhD
Understanding and Clinical Practice of Vascular Abnormalities in Keloid Disease.
Chengcheng Deng, PhD
BMP2-Induced Adam12+ Fibroblasts Dictate Skin Scarring and Fibrosis.
Panel Discussion and Q/A
10:30-10:45
Coffee Break
Co-Chair: Jonathan Tsao, MD
Jonathan Tsao, MD
Adjuvant Radiotherapy for the Treatment of Keloids.
Henry Weatherburn, PhD
A Data-Based Approach to a Keloid Post-Excisional Radiotherapy Treatment (PERT) Pathway.
John Glees, MD, FRCR, DMRT
Case Studies of Patient Outcomes of Re-Treatment of Recurrent Keloid Tumours by Fractionated Superficial X-Ray Radiotherapy
Zhongling Qiu, MD
Isotope Therapy to Prevent Post-Surgical Keloid Recurrence.
Hui Yao, MD
Adjuvant, Post-Operative Electron Beam Irradiation in Treatment of Keloids.
Xu Jinhui, MD
Industry Sponsored Presentation: Superficial X-Ray Irradiation for Keloid Treatment.
Panel Discussion and Q/A
12:30-13:30
Lunch Break
Co-Chair: Henry Weatherburn, PhD
Jinglong Cai, PhD
Can Keloids Be Cured? Evidence-Based Criteria for Patient Selection and Treatment
Henry Weatherburn, PhD
A 15 Year Single Centre Audit of the Outcome of Fractionated Superficial X-Ray Radiotherapy Treatment of Recurrent Keloid Tumours.
Kamalendu Malakar, MD, PhD
Optimizing Radio-Tolerance of Skin Graft Following Keloidectomy
Wei Liu, MD, PhD
Use of Punch Biopsy Procedure to Treat Wide-Spread Keloids.
Xiaomei Han, MD
Full-Process Management of Auricular Keloids: The Role of the Innovative ABC Surgical Technique in a Multidisciplinary Treatment Framework.
Xiaodong Chen, MD, PhD
Nucleoresection Combined with Punch Extraction and Radiation Therapy: a Keloid Surgical Technique Worth Promoting.
15:00 – 15:15
Wenbo Wang, MD, PhD
Industry Sponsored Presentation: Application of Hyaluronic Acid and its Functional Technology in the Field of Scars.
15:15 – 15:30
Coffee Break
15:30 – 17:30
Co-Chair: Cecilia Li, MD, PhD
Cecilia Li, MD, PhD
Novel Concept and Clinical Practice of Keloid Pressure Therapy
Eva Chintia Yessica Manalu, BMedSc
Bridging a Therapeutic Gap: Hydrocortisone Occlusion Dressing after Keloid Excision in Indonesia’s National Referral Hospital – A Case Series.
Patricia Yap, MD
Keloid Tumors and Telemedicine – a Patient’s Journey.
Haiguang Zhao, MD, PhD
Combining Laser and Intralesional Therapies in Treating Keloids.
Bingrong Zhou, MD, PhD
Novel Needle-Type Electrocoagulation and Combination Pharmacotherapy: Basic and Clinical Studies on Efficacy and Safety in Treating Keloids.
Time
Speaker
Title
DAY 3
Sunday June 8, 2025
Co-Chair: Dan Deng, MD, PhD
Michael H. Tirgan, MD
Pediatric Keloids: Case Review, Clinical Patterns, and Treatment Recommendations.
Dan Deng, MD, PhD
Pediatric Keloid Experience and Treatment at Shanghai Children’s Medical Center
Wei Liu, MD, PhD
Therapeutic Principles for Pediatric Keloids.
Xiqiao Wang, MD
Microbiome Dysbiosis Dominated by Rhodococcus Occurs in Keloids
Juliette Louter
How do I Deal with the Keloid Disease: a Qualitative Study Exploring Coping Strategies in a Multicultural Adult Patient Population.
Lina Ndjock Mbolong, MD
Understanding the Emotional Impact of Living with Keloids.
Panel Discussion and Q/A
10:45-11:00
Coffee Break
Co-Chair: Chunhui Xie, MD, PhD
Chunhui Xie, MD
Application of Core Excision in the Treatment of Keloids.
Yan Hao, MD
Clinical Observation of Subepidermal Vascular Network Flaps in Keloid Patients.
Bing Li, MD, PhD
Surgery Approaches and Experiences for Keloid Treatment and the Adjunctive Therapy.
Wenbo Wang, MD, PhD
An Innovative Single-Stage Approach of High-Tension Keloid Excision and Reconstruction Using Acellular Dermal Matrix and Epidermal Skin Grafting
Michael H Tirgan, MD
Cartesian Model of Clinical Behavior of Keloid Disorder.
Panel Discussion and Q/A
12:30-13:30
Lunch Break
Co-Chair: Lamont Jones, MD, PhD
Akash Gunjan, PhD
Rationale Based Repurposing of FDA-Approved Agents for Keloid Management: An in Vitro Study.
Lian Zhang, MD
Integrated Multi-Omics Unveils the Epigenetic Landscape in the Pathogenesis of Keloid.
Tianhao Li, PhD
TWIST1 Promote TGF-β Receptor I in Keloid Fibroblasts via Regulating the Stability of MEF2A.
Tianhao Li, PhD
Integrated Analysis of TWIST1 in Keloid Pathogenesis: Single-Cell Transcriptomics Reveals Fibroblast Heterogeneity and a Novel MEF2A-TBR1 Regulatory Axis.
Mengjie Shan, MD, PhD
Multi-Omics Analyses Reveal Bacteria and Catalase Associated with Keloid Disease.
Yixin Sun, MD, PhD
Single-Cell RNA Sequencing Revealed Key Factors of EMT to Promote Fibroblast Activation and Immune Infiltration in Keloid
Junxian Wen, PhD Candidate
Endothelial Dysfunction in Keloid Formation and Therapeutic Insights.
Zonan Chen, MD, PhD
Keloids and Inflammation: The Critical Role of IL-33 in Epidermal Changes.
15:15 – 15:30
Coffee Break
15:30 – 17:00
Co-Chair: Michael Tirgan, MD
Michael Tirgan, MD
Contact Cryotherapy in Treatment of Keloid Lesions: Indications and Case Studies.
Yingrou Tan, PhD
Dual siRNAs Nanoplex Targeting IL-4RA and SPARC Enhance Collagen Reduction in IL-4 Activated Skin Fibroblasts.
Qiannan Li, MD, PhD
Tissue Chondrification and Ossification in Keloids: Report of Five Cases.
Xinwen Kuang, MD, PhD candidate
Multi-Dimensional Effects of Hydrogen-Rich Materials on Wound Healing and Alleviating Skin Fibrosis.
Zhijin Li, PhD
Unraveling the Vascular Tapestry: Endothelial Dysfunction in Keloid Formation and Therapeutic Insights.
Shuo Li, MD, PhD
Establishment of a Deep Learning-Based Automated Segmentation and Blood Perfusion Prediction System for Keloids.
